BCG downregulates PD1 and PD-L1 expression in bladder cancer cells co-cultivated with peripheral blood mononuclear cells

Abstract Purpose BCG is the standard of care to treat high risk non-muscle invasive bladder cancer (NMIBC), reducing recurrence. PD-L1 is a ligand of the co-inhibitory receptor PD1 that has been shown to be expressed by tumor cells of distinct origin related to unfavorable prognosis. The development...

Full description

Saved in:
Bibliographic Details
Main Authors: Katia R. M. Leite (Author), Denis Reis Morais (Author), Cristina Massoco (Author), Sabrina T. Reis (Author), Nayara I. Viana (Author), Iran A. Silva (Author), Vanessa Guimaraes (Author), Ruan Pimenta (Author), Gabriel Arantes (Author), Miguel Srougi (Author), Willian Carlos Nahas (Author)
Format: Book
Published: BMC, 2022-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available